Brussels, 08 May 2002
In reaching its common position, the EU's Sixth Framework Programme for Research and Development, a five-year scheme with planned funding of €17.5bn, Council took on board numerous amendments approved by Parliament at first reading but was not able to come to an agreement on the wording of the legislation relating to cloning. The committee is therefore retabling the amendment from first reading which bans EU finance for research activity into human cloning for reproductive purposes, the creation of embryos for research purposes and research activity which would lead to the modification of the genetic heritage of human beings.
Amendments retabled from first reading support:
- health research to be extended beyond the field of genomics;
the integration of sustainable development and the reduction of external environmental
costs;- the promotion of basic research and space research;- the inclusion of research into health risks and health improvements;- increased participation of SMEs in all areas of the framework programme;- research into the preservation of the cultural heritage.
Gérard CAUDRON (PES, F)
Report on the Council common position for adopting a European Parliament and Council decision on the Sixth Framework Programme of the European Community for research, technological development and demonstration activities, contributing to the creation of the European Research Area and to innovation (2002-2006)
(15483/3/2001 - C5-0036/2002 - 2001/0053(COD))
Doc.: A5-0153/2002 [may not be available yet]
Procedure: Codecision procedure (2nd reading)
Debate: 14.05.200
European Parliament Briefing 2002-05-13 http://www.europarl.eu.int/home/default _en.htm
Register to continue
Why register?
- Registration is free and only takes a moment
- Once registered, you can read 3 articles a month
- Sign up for our newsletter
Subscribe
Or subscribe for unlimited access to:
- Unlimited access to news, views, insights & reviews
- Digital editions
- Digital access to THE’s university and college rankings analysis
Already registered or a current subscriber?